Cargando…

Porcine vs bovine surfactant therapy for preterm neonates with RDS: systematic review with biological plausibility and pragmatic meta-analysis of respiratory outcomes

BACKGROUND: Bovine surfactants are known to be clinically equivalent but it is unclear if porcine or bovine surfactants at their licensed dose should be preferred to treat respiratory distress syndrome in preterm neonates. METHODS: We performed a comprehensive review of biochemical and pharmacologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tridente, Ascanio, De Martino, Lucia, De Luca, Daniele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366095/ https://www.ncbi.nlm.nih.gov/pubmed/30728009 http://dx.doi.org/10.1186/s12931-019-0979-0

Ejemplares similares

Porcine versus bovine surfactant therapy for RDS in preterm neonates: pragmatic meta-analysis and review of physiopathological plausibility of the effects on extra-pulmonary outcomes
por: Foligno, Silvia, et al.
Publicado: (2020)

RDS-NExT workshop: consensus statements for the use of surfactant in preterm neonates with RDS
por: Bhandari, Vineet, et al.
Publicado: (2023)

Estimation of early life endogenous surfactant pool and CPAP failure in preterm neonates with RDS
por: Raschetti, Roberto, et al.
Publicado: (2019)

Techniques to evaluate surfactant activity for a personalized therapy of RDS neonates
por: Autilio, Chiara
Publicado: (2021)

Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS
por: Ramanathan, R
Publicado: (2006)

Early surfactant replacement guided by lung ultrasound in preterm newborns with RDS: the ULTRASURF randomised controlled trial
por: Rodriguez-Fanjul, Javier, et al.
Publicado: (2020)

Regulation of PACAP receptors in respiratory distress syndrome (RDS) of preterms and newborns
por: Müller, MJ, et al.
Publicado: (2015)

Identification of Novel Biomarkers in Late Preterm Neonates with Respiratory Distress Syndrome (RDS) Using Urinary Metabolomic Analysis
por: Christopoulou, Irene, et al.
Publicado: (2023)

Exogenous pulmonary surfactant in COVID-19 ARDS. The similarities to neonatal RDS suggest a new scenario for an ‘old’ strategy
por: Bhatt, Reena M, et al.
Publicado: (2021)

Cerebral oxygenation and bioelectrical activity in preterm infants during surfactant replacement therapy with porcine and bovine preparations
por: Szczapa, Tomasz, et al.
Publicado: (2020)

NIPPV after Surfactant Treatment for RDS Reduces the Need for Mechanical Ventilation at 7 Days of Age and BPD in Preterm Infants: Interpret Results with Caution
por: Shah, Vibhuti, et al.
Publicado: (2012)

Frequency Modulation and Spatiotemporal Stability of the sCPG in Preterm Infants with RDS
por: Barlow, Steven M., et al.
Publicado: (2012)

Comparison of Complications and Efficacy of NIPPV and Nasal CPAP in Preterm Infants With RDS
por: Esmaeilnia, Tahereh, et al.
Publicado: (2016)

Cerebral oxygenation associated with INSURE versus LISA procedures in surfactant‐deficient newborn piglet RDS model
por: Rey‐Santano, Carmen, et al.
Publicado: (2019)

Surfactant Treatment Shows Higher Correlation Between Ventilator and EIT Tidal Volumes in an RDS Animal Model
por: Kim, Yoon Zi, et al.
Publicado: (2022)

Comparison of Serum Triglyceride and Cholesterol Levels in Premature Neonates with or without Respiratory Distress Syndrome (RDS)
por: Kelishadi, Roya, et al.
Publicado: (2021)

RDS: the radio data system
por: Kopitz, Dietmar, et al.
Publicado: (1999)

Effects of bovine lipid extract surfactant administration in preterm infants treated for respiratory distress syndrome
por: Stockley, Elizabeth, et al.
Publicado: (2018)

Surfactant treatment before first breath for respiratory distress syndrome in preterm lambs: comparison of a peptide-containing synthetic lung surfactant with porcine-derived surfactant
por: van Zyl, Johann M, et al.
Publicado: (2013)

Sepsis 3 and the burns patient: do we need Sepsis 3.1?
por: Tridente, Ascanio
Publicado: (2018)

Colloid resuscitation in burns: controversies and perspectives
por: Tridente, Ascanio
Publicado: (2016)

Introducing video content into Scars, Burns & Healing
por: Tridente, Ascanio
Publicado: (2020)

Non-invasive neurally adjusted ventilatory assist in preterm infants with RDS: effect of changing NAVA levels
por: Lefevere, Julie, et al.
Publicado: (2021)

Characteristics and outcomes of preterm neonates according to number of doses of surfactant received
por: Coshal, Hanita, et al.
Publicado: (2020)

Thresholds for surfactant use in preterm neonates: a network meta-analysis
por: Branagan, Aoife, et al.
Publicado: (2023)

Surfactant Protein A and B Gene Polymorphisms and Risk of Respiratory Distress Syndrome in Late-Preterm Neonates
por: Tsitoura, Maria-Eleni I., et al.
Publicado: (2016)

The Common Haplotype GATGACA in Surfactant-Protein B Gene Is Protective for Respiratory Distress Syndrome in Preterm Neonates
por: Mikolajcikova, Silvia, et al.
Publicado: (2022)

Outcomes at 7 Years of Age of Former Very Preterm Neonates with Repeated Surfactant Treatment for Prolonged Respiratory Distress in the Neonatal Period
por: Hascoet, Jean-Michel, et al.
Publicado: (2023)

Differential attainment and recruitment to Intensive Care Medicine Training in the UK, 2018–2020
por: Tridente, Ascanio, et al.
Publicado: (2022)

The Influence of the Technique of Surfactant Administration (LISA vs INSURE) on the Outcomes of Respiratory Distress Syndrome Treatment in Preterm Infants
por: Kaniewska, Urszula, et al.
Publicado: (2019)

Can lung ultrasound score accurately predict the need for surfactant replacement in preterm neonates? A systematic review and meta-analysis protocol
por: Capasso, Letizia, et al.
Publicado: (2021)

Dose Effect of Poractant Alfa in Neonatal RDS: Analysis of Combined Data from Three Prospective Studies
por: Królak-Olejnik, Barbara, et al.
Publicado: (2020)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021)

Effect of Nasal Continuous Airway Pressure With and Without Surfactant Administration for the Treatment of Respiratory Distress Syndrome in Preterm Neonates
por: Malibary, Husam, et al.
Publicado: (2023)

Comparison of the efficacy of two natural surfactants (BERAKSURF and BLES) in the treatment of respiratory distress syndrome among preterm neonates
por: Sabzevari, Fatemeh, et al.
Publicado: (2023)

Sonographic prediction of fetal main pulmonary artery (MPA) Doppler indices of lung maturity and neonatal respiratory distress syndrome (RDS) development
por: Hassan, Hend Galal Eldeen Mohamed Ali, et al.
Publicado: (2023)

LocaRDS: A Localization Reference Data Set
por: Schäfer, Matthias, et al.
Publicado: (2021)

RETREATMENT WITH SURFACTANT IN VERY LOW BIRTH WEIGHT PRETERM INFANTS: RISK PREDICTORS AND THEIR INFLUENCE ON NEONATAL OUTCOMES
por: Ferri, Walusa Assad Gonçalves, et al.
Publicado: (2020)

Safety and efficacy of a novel double-lumen tracheal tube in neonates with RDS: A prospective cohort study
por: Li, Chuanfeng, et al.
Publicado: (2022)

Differences in Clinical Characteristics and Therapy of Neonatal Acute Respiratory Distress Syndrome (ARDS) and Respiratory Distress Syndrome (RDS): A Retrospective Analysis of 925 Cases
por: Luo, JingHua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7hp21gvdb9nprao2pbnu0ak5vs